• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Affinity Bio Partners launches Pennsylvania cannabis biotech company

Affinity Bio Partners launches Pennsylvania cannabis biotech company

August 15, 2017
CenterWatch Staff

Affinity Bio Partners CEO Christina DiArcangelo Puller announced that she is adding another organization to the Affinity family of organizations by launching Affinity BioCeuticals, a "first of its kind" Cannabis Biotech Pennsylvania corporation. Affinity BioCeuticals is a Neutraceutical company focused on research and development of cannabinoid based therapies. The emergence of more and more indications where cannabinoid based treatment may be impactful to patient’s lives will be the primary focus for Affinity BioCeuticals. 

“As we have seen through numerous studies that Affinity Bio Partners has had exposure to, cannabis and cannabis-based products can be very effective in treating a broad range of therapeutic areas. The Medical Cannabis market is emerging and it is time that Clinical Trial Protocols are developed in order to maximize efficacy and safety in patients that fall into these therapeutic areas,” said CEO, Christina DiArcangelo Puller. “Our goal is to ensure that Medical Cannabis is being utilized in the correct manner, while additionally ensuring that safe dosing protocols are being considered in the delivery methods. It is our organization's intent that through the utilization of Affinity Bio Partners’ CRO Services (clinical operations, safety, data management, regulatory services) we will achieve clinical trial results in a more efficient and rapid manner. This in turn will provide much needed relief to the many ill patients that are in desperate need of relief. As the CEO of each of the Affinity organizations, it is important to me that we always focus on helping provide assistance to unmet treatment needs for patients.”

Affinity BioCeuticals initially intends to focus its efforts on: 
• Opioid abuse 
• PTSD 
• Anxiety 
• Oncology supportive care 

Affinity BioCeuticals is led by a highly qualified team of executives with decades of biopharmaceutical, healthcare experience and significant background in drug development.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing